In promoter regions, functional polymorphisms of the IL-10 gene such as -592C/A can lead to changes in the affinity of transcriptional factors, thereby altering levels of mRNA expression (dose-dependent effect) of inflammatory cytokines associated with the occurrence of cancer [22, 45]. This evidence concerns the gene IL10 and cancer.